Bank of America’s Citius Oncology CTOR Stock Holding History
Bought
Maintained
Sold
Other funds holding CTOR
AC
VCM
VFT
IA
AWA
Bank of America's CTOR Position: Q1 2026 in Review
Bank of America increased its Citius Oncology (CTOR) stake by 1,792,031% in Q1 2026, buying an estimated $3.85M and bringing the position to 3,835,160 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #3999.
Bank of America first reported a position in CTOR in Q3 2024 and has held it in 7 quarters since. 14 funds tracked by Wall St. Rank hold CTOR as of Q1 2026.
- Bank of America held 3,835,160 shares of Citius Oncology worth $2.37M as of Q1 2026.
- Bank of America bought 3,834,946 Citius Oncology shares in Q1 2026, an estimated $3.85M.
- Citius Oncology made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3999 holding.
- Bank of America first reported a position in Citius Oncology in Q3 2024 and has held it in 7 quarters since.
- 14 funds tracked by Wall St. Rank held Citius Oncology as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.